94 related articles for article (PubMed ID: 7553602)
1. Tamoxifen and somatostatin affect tumours by inducing apoptosis.
Candi E; Melino G; De Laurenzi V; Piacentini M; Guerrieri P; Spinedi A; Knight RA
Cancer Lett; 1995 Sep; 96(1):141-5. PubMed ID: 7553602
[TBL] [Abstract][Full Text] [Related]
2. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.
Otto AM; Paddenberg R; Schubert S; Mannherz HG
J Cancer Res Clin Oncol; 1996; 122(10):603-12. PubMed ID: 8879258
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C.
Zhang W; Lawa RE; Hintona DR; Su Y; Couldwell WT
Cancer Lett; 1995 Sep; 96(1):31-5. PubMed ID: 7553605
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of apoptotic and autophagic induction by a novel synthetic C-1 analogue of 7-deoxypancratistatin in human breast adenocarcinoma and neuroblastoma cells with tamoxifen.
Ma D; Collins J; Hudlicky T; Pandey S
J Vis Exp; 2012 May; (63):. PubMed ID: 22688195
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
Perry RR; Kang Y; Greaves BR
Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
[TBL] [Abstract][Full Text] [Related]
7. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage.
Wilson JW; Wakeling AE; Morris ID; Hickman JA; Dive C
Int J Cancer; 1995 May; 61(4):502-8. PubMed ID: 7759156
[TBL] [Abstract][Full Text] [Related]
8. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
[TBL] [Abstract][Full Text] [Related]
9. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
Kim J; Lee J; Kim C; Choi J; Kim A
Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
12. MTDH mediates estrogen-independent growth and tamoxifen resistance by down-regulating PTEN in MCF-7 breast cancer cells.
Xu C; Kong X; Wang H; Zhang N; Kong X; Ding X; Li X; Yang Q
Cell Physiol Biochem; 2014; 33(5):1557-67. PubMed ID: 24854844
[TBL] [Abstract][Full Text] [Related]
13. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.
Ma ZL; Chen YP; Song JL; Wang YQ
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2394-9. PubMed ID: 26214774
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
Thomas M; Monet JD
J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro.
Chen H; Tritton TR; Kenny N; Absher M; Chiu JF
J Cell Biochem; 1996 Apr; 61(1):9-17. PubMed ID: 8726350
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
Lykkesfeldt AE; Larsen JK; Christensen IJ; Briand P
Br J Cancer; 1984 Jun; 49(6):717-22. PubMed ID: 6733020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
